Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px

News > All

Find below news from the Portugal and Spain. Listed are news about these countries as well as from organisations located there.

Total search results: 309 | Ordered by Date (descending)
1 2 3 4  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
[iito] Business Intelligence. (–). "THIS IS A BETA VERSION! NOT INTENDED FOR PUBLIC USE! The official launch of Life-Sciences-Spain.com will be announced in due time by [iito] Business Intelligence". 2020-01-01
[iito] Business Intelligence. (–). "THIS IS A BETA VERSION! NOT INTENDED FOR PUBLIC USE! The official launch of Life-Sciences-Spain.com will be announced in due time by [iito] Business Intelligence". 2020-01-01
[iito] Business Intelligence. (–). "THIS IS A BETA VERSION! NOT INTENDED FOR PUBLIC USE! The official launch of Life-Sciences-Spain.com will be announced in due time by [iito] Business Intelligence". 2020-01-01
Sygnis AG. (10/24/17). "Press Release: Sygnis AG Announces the Launch of the Universal Lateral Flow Assay Kit and Associated Patent Filing". Madrid & Heidelberg. 2017-10-24
Aelix Therapeutics. (10/20/17). "Press Release: Aelix Therapeutics Appoints Dr. Thomas Hecht as Chairman of the Board of Directors". 2017-10-20
Sygnis AG. (10/18/17). "Press Release: Sygnis AG Announces Completion of Relocation of Its Innova Biosciences Unit to Allow for Expansion". Madrid & Heidelberg. 2017-10-18
Optibrium Ltd.. (10/10/17). "Press Release: Optibrium Joins EUR 40 Million eTRANSAFE Project". Cambridge. 2017-10-10
Cytel Inc.. (10/6/17). "Press Release: Cytel Adds New Basel Location In Continued Expansion". 2017-10-06
Oryzon Genomics S.A.. (10/3/17). "Press Release: Significant Fact [Company Moves Registered Address from Barcelona to Madrid]". Madrid. 2017-10-03
Roche. (10/3/17). "Press Release: Roche Launches Navify Tumor Board Solution to Provide Decision Support to Oncology Care Teams". Basel. 2017-10-03
Ability Pharmaceuticals S.L.. (9/18/17). "Press Release: Ability Pharmaceuticals Announces EMA-Orphan Drug Designation for ABTL0812 in Pancreatic Cancer". Barcelona. 2017-09-18
Abivax S.A.. (9/18/17). "Press Release: First Patient Dosed in Three-month Cohort of Phase 2A Study of Oral ABX464 in HIV-supressed Patients". Paris. 2017-09-18
Roche. (9/8/17). "Press Release: Roche Announces Progress in Biomarker Science in Cancer Immunotherapy at the European Society for Medical Oncology Congress". Basel. 2017-09-08
Aelix Therapeutics. (9/5/17). "Press Release: Aelix Therapeutics Enrolls First Patient in Company’s Initial Therapeutic HIV Vaccine Clinical Trial". 2017-09-05
Merck KGaA. (8/31/17). "Press Release: Driving Innovation in Cancer Care at ESMO 2017 with New Data in Hard-to-Treat Cancers [Not intended for U.K. or U.S. based media]". Darmstadt. 2017-08-31
Thermo Fisher Scientific Inc.. (8/29/17). "Press Release: Thermo Fisher Scientific Completes Acquisition of Patheon". Waltham, MA. 2017-08-29
Almirall S.A.. (8/28/17). "Press Release: Almirall Appoints Peter Guenter as New CEO". Barcelona. 2017-08-28
Amcure GmbH. (8/23/17). "Press Release: Amcure Announces Formation of Inaugural Scientific Advisory Board". Eggenstein-Leopoldshafen. 2017-08-23
SpectralWorks Ltd.. (8/15/17). "Press Release: SpectralWorks and Mestrelab Research SL Announce Mutual Reseller Agreement". 2017-08-15
Sygnis AG. (8/3/17). "Press Release: Sygnis AG Reports Financial Results for the Second Quarter and First Six Months of 2017". Madrid & Heidelberg. 2017-08-03
Grifols S.A.. (7/28/17). "Press Release: Grifols Increases Its Revenues by 12.3% to EUR 2,192 Million Driven by Growth of Its Main Divisions". Barcelona. 2017-07-28
AB Sciex (d/b/a Sciex). (7/27/17). "Press Release: Sciex Equipment Is Now Available Through a Wide Range of Flexible Financing Packages via Evosciences". Warrington. 2017-07-27
Oryzon Genomics S.A.. (7/20/17). "Press Release: Oryzon to Regain Rights to ORY-1001 (RG6016)". Barcelona & Cambridge, MA. 2017-07-20
Grifols S.A.. (7/5/17). "Press Release: Grifols Strengthens Its R&D+i through Investee Companies. Grifols Opens New Lines of Research with the Acquisition of a 44% Stake in GigaGen for USD 35 Million". Barcelona. 2017-07-05
Cellnovo. (6/29/17). "Press Release: Cellnovo Expands International Distribution Network". Paris. 2017-06-29
Invent Farma Holding Spain S.L.. (6/21/17). "Press Release: Invent Farma / Neuraxpharm Group Announces the Acquisition of FB Health in Italy". Barcelona & Düsseldorf. 2017-06-21
OBN (UK) Ltd.. (6/20/17). "Press Release: OBN (UK) and Eurasanté (FR) Announce the Launch of BioSeed. A New European Equity Investment Event to Support Early-Stage Companies in Life Sciences". Oxford. 2017-06-20
Sygnis AG. (6/6/17). "Press Release: Sygnis AG Announces Management and Supervisory Board Changes. Dr. Heikki Lanckriet Sole CEO". Madrid & Heidelberg. 2017-06-06
AB Sciex (d/b/a Sciex). (6/1/17). "Press Release: Sciex Launches Its Unrivalled Swath Data Independent Acquisition Technology for Comprehensive Analysis of Food, Forensic and Environmental Samples". Framingham, MA. 2017-06-01
Oryzon Genomics S.A.. (5/31/17). "Press Release: Oryzon Genomics to Participate in a Panel at the JMP Securities Life Sciences Conference and Present at the Jefferies 2017 Global Health Conference". Barcelona & Cambridge, MA. 2017-05-31
PharmaMar S.A.. (5/18/17). "Press Release: PharmaMar Announces New Data with Its Compounds Yondelis and Lurbinectedin during ASCO 2017". Madrid. 2017-05-18
AptaTargets. (5/17/17). "Press Release: AptaTargets Closes €2.7 Million Round of Funding for New Stroke Treatment". Madrid. 2017-05-17
Cinfa Biotech S.L.. (5/17/17). "Press Release: Cinfa Biotech Announces Positive Top-line Data from Second Clinical Study with Pegfilgrastim Biosimilar Candidate B12019". Pamplona. 2017-05-17
PharmaMar S.A.. (5/17/17). "Press Release: PharmaMar and Specialised Therapeutics Asia Sign Licensing and Marketing Agreement for Lurbinectedin Covering Australia, New Zealand and Several Asian Countries". Madrid. 2017-05-17
Oryzon Genomics S.A.. (5/16/17). "Press Release: Oryzon Announces Appointment of New Chief Medical Officer and Expansion of Its Medical Department". Barcelona & Cambridge, MA. 2017-05-16
ThromboGenics N.V.. (5/11/17). "Press Release: ThromboGenics Business Update – Q1 2017. Progressing Innovative Diabetic Eye Disease Clinical and Pre-Clinical Portfolio". Leuven. 2017-05-11
Celyad S.A.. (5/11/17). "Press Release: FDA Grants Fast Track Designation for Celyad’s Ischemic Heart Failure Therapy, C-Cure". Mont-Saint-Guibert. 2017-05-11
Sygnis AG. (5/8/17). "Press Release: Sygnis AG Plans to Acquire Profitable Innova Biosciences Ltd. for EUR 8 Million in Cash and up to 3.5 Million Shares [Not for USA, Canada, Japan and Australia]". Madrid & Heidelberg. 2017-05-08
PharmaMar S.A.. (5/4/17). "Press Release: Aplidin Receives Orphan Drug Status for the Treatment of Multiple Myeloma in Switzerland". Madrid. 2017-05-04
Vivet Therapeutics S.A.S.. (5/4/17). "Press Release: Vivet Therapeutics Raises €37.5 Million in Series A Financing Round to Advance Novel Gene Therapies for Treating Inherited Metabolic Diseases". Paris. 2017-05-04
Celyad S.A.. (5/3/17). "Press Release: Celyad to Present at the Deutsche Bank 42nd Annual Health Care Conference". Mont-Saint-Guibert. 2017-05-03
Abivax S.A.. (5/2/17). "Press Release: First Ever Evidence of Treatment-induced Reduction in HIV Reservoirs". Paris. 2017-05-02
Celyad S.A.. (5/2/17). "Press Release: Celyad Grants to Novartis a Non-exclusive License for Its Allogeneic TCR-deficient CAR-T Cells Patents". Mont-Saint-Guibert. 2017-05-02
Medigene AG. (4/28/17). "Press Release: Medigene Announces Participation at Six International Conferences". Planegg. 2017-04-28
Sygnis AG. (4/27/17). "Press Release: Sygnis AG Reports Financial Results for Fiscal Year 2016". Madrid & Heidelberg. 2017-04-27
Enamine Ltd.. (4/25/17). "Press Release: Enamine to Collaborate with EMBL for Cancer Drug Discovery Research". Kiev. 2017-04-25
Sygnis AG. (4/24/17). "Press Release: Sygnis AG Expands Access to Chinese Market with Second OEM Deal with Tanon". Madrid & Heidelberg. 2017-04-24
Sygnis AG. (4/11/17). "Press Release: Sygnis AG Successfully Completes Integration of Recently Acquired C.B.S. Scientific". Madrid & Heidelberg. 2017-04-11
Oryzon Genomics S.A.. (3/31/17). "Press Release: Oryzon Raises €18 Million through a Private Placement with US and European Investors [Not for US, CA, AU, JP, ZA, et al.]". Barcelona. 2017-03-31
AB Science S.A.. (3/31/17). "Press Release: AB Science Announces the Success of a Private Placement [Not for US, CA or JP]". Paris. 2017-03-31
Neovacs S.A.. (3/30/17). "Press Release: Neovacs Provides Corporate Update and Reports Full Year 2016 Financial Results". Paris. 2017-03-30
Versantis AG. (3/29/17). "Press Release: Versantis Raises CHF 4.4 Million in Series A Financing to Advance New Generation of Liver Disease Medicines". Zurich. 2017-03-29
Medigene AG. (3/28/17). "Press Release: Medigene Announces Participation at Six National and International Conferences". Planegg. 2017-03-28
AB Science S.A.. (3/27/17). "Press Release: AB Science Announces the Success of a Private Placement [Not for US, CA or JP]". Paris. 2017-03-27
BioClin Therapeutics, Inc.. (3/22/17). "Press Release: BioClin Therapeutics, Inc., Raises $30 Million in Series B Financing Led by Sofinnova Ventures and Ysios Capital". San Ramon, CA. 2017-03-22
Medivir AB. (3/16/17). "Press Release: Medivir Completes Transition of Commercial Products to Fully Focus on Research and Development". Stockholm. 2017-03-16
Alimera Sciences, Inc.. (3/13/17). "Press Release: Alimera Sciences Signs Agreement for Exclusive Distributor of Iluvien in Spain". Atlanta, GA. 2017-03-13
Newron Pharmaceuticals S.p.A.. (3/2/17). "Press Release: Newron Announces 2016 Financial Results and Provides Outlook for 2017". Milan. 2017-03-02
Eurofins Scientific. (2/28/17). "Press Release: Eurofins Achieves Its Recently-upgraded 2016 Objectives and Delivers Its Best Year Ever on Sustained Growth Momentum". 2017-02-28
Minoryx Therapeutics S.L.. (2/22/17). "Press Release: Minoryx Therapeutics Receives Orphan Drug Designation from the US FDA for Its Lead Candidate MIN-102". Mataró, Barcelona. 2017-02-22
EFPIA. (2/22/17). "Press Release: Nathalie Moll Announced as New EFPIA Director General, Starting in April 2017". 2017-02-22
mAbxience S.L.. (2/13/17). "Press Release: mAbxience, European Success Accelerating Global Growth". 2017-02-13
Minoryx Therapeutics S.L.. (2/8/17). "Press Release: Dr Claude Nicaise Joins Minoryx Therapeutics as Independent Board Member". Mataró, Barcelona. 2017-02-08
Forbion Capital Partners. (2/7/17). "Press Release: Forbion Invests in Prexton Therapeutics’ EUR 29 Million (USD 31 Million) Series B Financing". Naarden. 2017-02-07
Medigene AG. (2/2/17). "Press Release: Medigene Participates at Five National and International Conferences in February and March 2017". Martinsried. 2017-02-02
Sygnis AG. (2/2/17). "Press Release: Sygnis AG Announces the Launch of TrueHelix". Madrid & Heidelberg. 2017-02-02
Iproteos S.L.. (1/26/17). "Press Release: Grant of 700,000 € for the Discovery of Drugs against Atherosclerosis". 2017-01-26
Minoryx Therapeutics S.L.. (1/18/17). "Press Release: Minoryx Therapeutics Further Strengthens Its Scientific Advisory Board (SAB)". Mataró, Barcelona. 2017-01-18
Eurofins Scientific. (12/29/16). "Press Release: Eurofins Reinforces Its Footprint in Discovery Pharmacology with the Acquisition of Villapharma in Spain". 2016-12-29
Sygnis AG. (12/21/16). "Press Release: Sygnis AG Acquires Profitable US Life Sciences Tools Company C.B.S. Scientific for US $0.9 Million in Cash and Shares". Madrid & Heidelberg. 2016-12-21
TiGenix N.V.. (12/15/16). "Press Release: TiGenix Raises $35.65 Million Gross Proceeds with NASDAQ IPO". Leuven. 2016-12-15
Grifols S.A.. (12/14/16). "Press Release: Grifols Agrees to Acquire Hologic's Share of NAT Donor Screening Unit for USD 1,850 Million". Barcelona. 2016-12-14
Minoryx Therapeutics S.L.. (12/14/16). "Press Release: Minoryx Therapeutics Receives European Orphan Drug Designation for Its Lead Candidate MIN-102". Mataró, Barcelona. 2016-12-14
MolMed S.p.A.. (12/12/16). "Press Release: MolMed Coordinates a CAR T-cell Immunotherapy Project Awarded a 5.9 million Euro Grant by the European Commission". Milan. 2016-12-12
SGS S.A.. (12/9/16). "Press Release: SGS Acquires 70 Percent Stake in Biopremier, Portugal". 2016-12-09
PharmaMar S.A.. (12/1/16). "Press Release: PharmaMar Presents Positive Results with Its Conjugated Antibody MI130110 in CD13-expressing Tumor-cells". Madrid. 2016-12-01
OxThera AB. (11/29/16). "Press Release: OxThera Raises EUR 32 Million to Complete Development of Oxabact for Treatment of Primary Hyperoxaluria". Stockholm. 2016-11-29
Sygnis AG. (11/28/16). "Press Release: Sygnis AG Reinforces Its Proteomics Portfolio with Two Patents Granted in Europe and China". Madrid & Heidelberg. 2016-11-28
PharmaMar S.A.. (11/28/16). "Press Release: PharmaMar Begins a Phase I Study of PM1183 in Japan for the Treatment of Solid Tumors". Madrid. 2016-11-28
Neovacs S.A.. (11/23/16). "Press Release: Neovacs Signs Production Partnership with 3P Biopharmaceuticals, a Leading GMP Producer of Biological Drugs". Paris & Boston, MA. 2016-11-23
Bruker Corporation. (11/22/16). "Press Release: Bruker Completes Acquisition of Preclinical PET Imaging Business". Billerica, MA. 2016-11-22
Ability Pharmaceuticals S.L.. (11/22/16). "Press Release: Ability Pharmaceuticals Initiates Phase 2 Combination Trial with ABTL0812 as First Line Therapy in Patients with Endometrial or Squamous Lung Cancer". Barcelona. 2016-11-22
Sygnis AG. (11/18/16). "Press Release: Sygnis AG to Present at Upcoming Investor Conferences". Madrid & Heidelberg. 2016-11-18
Sygnis AG. (11/16/16). "Press Release: Sygnis AG Launches TruePrime Liquid Biopsy Kit targeting Oncology Research and Diagnostics". Madrid & Heidelberg. 2016-11-16
PharmaMar S.A.. (11/16/16). "Press Release: PharmaMar Appoints Pascal Besman as Chief Operating Officer of PharmaMar U.S.". Madrid & New York, NY. 2016-11-16
PharmaMar S.A.. (11/10/16). "Press Release: PharmaMar Shows New Clinical Data with Yondelis in Different Sarcoma Subtypes at CTOS 2016". Madrid. 2016-11-10
Sygnis AG. (11/9/16). "Press Release: Sygnis AG Reports Nine Month Results for the Period Ended September 30, 2016". Madrid & Heidelberg. 2016-11-09
CorWave. (11/4/16). "Press Release: CorWave Raises $17.1 Million in Series B Financing". Paris. 2016-11-04
PharmaMar S.A.. (10/28/16). "Press Release: The EMA Accepts to Assess the Marketing Authorization Application from PharmaMar for Aplidin". Madrid. 2016-10-28
PharmaMar S.A.. (10/27/16). "Press Release: PharmaMar Group Reports 9M 2016 Financial Results". Madrid. 2016-10-27
Sygnis AG. (10/27/16). "Press Release: Sygnis AG to Receive €1.9 Million Non-dilutive R&D Funding from the Spanish Government". Madrid & Heidelberg. 2016-10-27
Onxeo S.A.. (10/27/16). "Press Release: Onxeo Announces Promising Results from Preclinical Study of Beleodaq Combination with Checkpoint Inhibitors". Paris & Copenhagen. 2016-10-27
OncoDNA S.A.. (10/26/16). "Press Release: OncoDNA Signs Agreement with SOLTI to Provide Tumor Molecular Profile Analysis to Breast Cancer Patients in AGATA Screening Program". Brussels & Barcelona. 2016-10-26
Iproteos S.L.. (10/25/16). "Press Release: Iproteos Closes a Round of Funding Valued at 1.5 Millon Euros". Barcelona. 2016-10-25
PharmaMar S.A.. (10/24/16). "Press Release: PharmaMar Announces the Opening of a New Affiliate in Austria". Madrid. 2016-10-24
Protagen AG. (10/18/16). "Press Release: Protagen AG Announces Changes to Their Management Board". 2016-10-18
Ysios Capital. (10/18/16). "Press Release: Ysios Capital Raises €126,4 m ($140 m) for Its Second Fund, Ysios Biofund II Innvierte". Barcelona. 2016-10-18
Selexis S.A.. (10/10/16). "Press Release: Selexis SA Announces Participation at Two Upcoming Industry Conferences". Geneva. 2016-10-10
PharmaMar S.A.. (10/4/16). "Press Release: PharmaMar and Boryung Pharm Sign a Licensing Agreement for Aplidin (plitidepsin) in Korea". Madrid. 2016-10-04
Eurofins Scientific. (9/30/16). "Press Release: Eurofins Expands Its Clinical Diagnostic Footprint with the Acquisition of Megalab in Spain". 2016-09-30
1 2 3 4  next pagenext page



Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px

» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px